Although there are many studies on PTK7 in hematologic malignancies, there are few studies exploring how PTK7 is involved in disease progression, and most of the current studies are directed toward therapeutic and clinical applications that target PTK7, which we will also address in more detail later. Here, PTK7 is linked to hematologic disorder.